Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
出版年份 2018 全文链接
标题
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
作者
关键词
-
出版物
CNS Neuroscience & Therapeutics
Volume 24, Issue 7, Pages 624-632
出版商
Wiley
发表日期
2018-04-15
DOI
10.1111/cns.12852
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neurovascular Unit Dysfunction and Blood–Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence
- (2017) Souhel Najjar et al. Frontiers in Psychiatry
- Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling
- (2017) Oli Sarkar et al. PLoS One
- Prediction of conversion to psychosis: review and future directions
- (2017) Dylan G. Gee et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
- (2016) J. M. Stone et al. PSYCHOLOGICAL MEDICINE
- Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model
- (2016) Camila Mauricio Santos et al. SCHIZOPHRENIA RESEARCH
- Declining transition rates to psychotic disorder in “ultra-high risk” clients: Investigation of a dilution effect
- (2016) Jessica A. Hartmann et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
- (2016) Fernanda F. Peres et al. Frontiers in Pharmacology
- Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
- (2015) Ludmyla Kandratavicius et al. BMC NEUROSCIENCE
- Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis
- (2015) Jose Crippa et al. CNS & Neurological Disorders-Drug Targets
- The role of nitric oxide donors in schizophrenia: Basic studies and clinical applications
- (2015) Nikolaos Pitsikas EUROPEAN JOURNAL OF PHARMACOLOGY
- The Effects of Sodium Nitroprusside Treatment on Cognitive Deficits in Schizophrenia
- (2015) Joao Paulo Maia-de-Oliveira et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Low expression of Gria1 and Grin1 glutamate receptors in the nucleus accumbens of Spontaneously Hypertensive Rats (SHR)
- (2015) Mariana C. Diana et al. PSYCHIATRY RESEARCH
- The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats
- (2015) Aikaterini Trevlopoulou et al. PSYCHOPHARMACOLOGY
- Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week
- (2015) Joao Paulo Maia-de-Oliveira et al. SCHIZOPHRENIA RESEARCH
- Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects
- (2015) Regina F. Nasyrova et al. Frontiers in Physiology
- Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: Relevance to neuropsychiatric disorders
- (2014) Marcos Leite Santoro et al. PSYCHIATRY RESEARCH
- Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
- (2014) Joao Paulo Maia-de-Oliveira et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Impact of neonatal NOS-1 inhibitor exposure on neurobehavioural measures and prefrontal-temporolimbic integration in the rat nucleus accumbens
- (2013) Alexander M. Dec et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice
- (2013) Ana C. Issy et al. PSYCHOPHARMACOLOGY
- Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside
- (2013) Jaime E. C. Hallak et al. JAMA Psychiatry
- Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
- (2012) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
- (2012) Raquel Levin et al. CURRENT PHARMACEUTICAL DESIGN
- Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice
- (2012) Kiersten S. Smith et al. NEUROPHARMACOLOGY
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats
- (2011) Mariana Bendlin Calzavara et al. BEHAVIOURAL BRAIN RESEARCH
- The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers
- (2011) Mariana Bendlin Calzavara et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine
- (2011) Raquel Levin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia
- (2011) João Paulo Maia de Oliveira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective
- (2010) Deborah Nicholl et al. CURRENT MEDICAL RESEARCH AND OPINION
- Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders
- (2010) Molly K Larson et al. Expert Review of Neurotherapeutics
- Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
- (2010) Yuichiro Nakano et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling
- (2009) A. Masood et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Neonatal administration of N-omega-nitro-l-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by d-amphetamine in postpubertal rats
- (2008) Julio César Morales-Medina et al. NEUROPHARMACOLOGY
- Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat
- (2008) Mark D. Black et al. PSYCHOPHARMACOLOGY
- Neuroleptic Drugs Revert the Contextual Fear Conditioning Deficit Presented by Spontaneously Hypertensive Rats: A Potential Animal Model of Emotional Context Processing in Schizophrenia?
- (2008) M. B. Calzavara et al. SCHIZOPHRENIA BULLETIN
- Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
- (2008) Bun-Hee Lee et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started